Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States.

Verma V, Haque W, Cushman TR, Lin C, Simone CB 2nd, Chang JY, McClelland S 3rd, Welsh JW.

J Immunother. 2019 Jan 8. doi: 10.1097/CJI.0000000000000253. [Epub ahead of print]

PMID:
30628924
2.

Stereotactic Body Radiation Therapy versus Thermal Ablation for Early Stage Non-Small Cell Lung Cancer.

Vyfhuis MAL, Mohindra P, Simone CB 2nd.

Radiology. 2019 Jan 1:182310. doi: 10.1148/radiol.2018182310. [Epub ahead of print] No abstract available.

PMID:
30599098
3.

Concurrent Radiation and Immunotherapy: Survey of Practice Patterns in the United States.

Amin NP, Remick J, Agarwal M, Desai NA, Bergom C, Simone CB 2nd.

Am J Clin Oncol. 2018 Dec 3. doi: 10.1097/COC.0000000000000501. [Epub ahead of print]

PMID:
30516568
4.

Automated data extraction and ensemble methods for predictive modeling of breast cancer outcomes after radiation therapy.

Lindsay WD, Ahern CA, Tobias JS, Berlind CG, Chinniah C, Gabriel PE, Gee JC, Simone CB 2nd.

Med Phys. 2018 Nov 30. doi: 10.1002/mp.13314. [Epub ahead of print]

PMID:
30499597
5.

Modeling Epidermal Growth Factor Inhibitor-mediated Enhancement of Photodynamic Therapy Efficacy Using 3D Mesothelioma Cell Culture.

Cramer G, Shin M, Hagan S, Katz SI, Simone CB 2nd, Busch TM, Cengel KA.

Photochem Photobiol. 2018 Nov 29. doi: 10.1111/php.13067. [Epub ahead of print]

PMID:
30499112
6.

A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.

Rice SR, Li YR, Busch TM, Kim MM, McNulty S, Dimofte A, Zhu TC, Cengel KA, Simone CB 2nd.

Photochem Photobiol. 2018 Nov 28. doi: 10.1111/php.13065. [Epub ahead of print]

PMID:
30485442
7.

Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer.

Molitoris JK, Simone CB 2nd.

JAMA Surg. 2018 Nov 21. doi: 10.1001/jamasurg.2018.4371. [Epub ahead of print] No abstract available.

PMID:
30477005
8.

Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.

Li H, Galperin-Aizenberg M, Pryma D, Simone CB 2nd, Fan Y.

Radiother Oncol. 2018 Nov;129(2):218-226. doi: 10.1016/j.radonc.2018.06.025. Epub 2018 Jul 4.

9.

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.

Verma V, Sprave T, Haque W, Simone CB 2nd, Chang JY, Welsh JW, Thomas CR Jr.

J Immunother Cancer. 2018 Nov 23;6(1):128. doi: 10.1186/s40425-018-0442-7. Review.

10.

Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial.

Jiang J, Li Y, Shen Q, Rong X, Huang X, Li H, Zhou L, Mai HQ, Zheng D, Chen MY, Xu Y, Li J, Hui X, Simone CB 2nd, Gaertner J, Argyriou AA, Chow E, Chen P, Tang Y.

J Clin Oncol. 2019 Jan 10;37(2):135-143. doi: 10.1200/JCO.18.00896. Epub 2018 Nov 20.

PMID:
30457920
11.

Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection.

Verma V, Ahern CA, Berlind CG, Lindsay WD, Grover S, Friedberg JS, Simone CB 2nd.

J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32793-4. doi: 10.1016/j.jtcvs.2018.10.039. [Epub ahead of print]

PMID:
30454981
12.

Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.

Demissei BG, Freedman G, Feigenberg SJ, Plastaras JP, Maity A, Smith AM, McDonald C, Sheline K, Simone CB 2nd, Lin LL, Carver JR, Liu P, Zhang L, Bekelman JE, Ky B.

Int J Radiat Oncol Biol Phys. 2018 Nov 14. pii: S0360-3016(18)33999-3. doi: 10.1016/j.ijrobp.2018.11.013. [Epub ahead of print]

PMID:
30445173
13.

ASO Author Reflections: Management of Malignant Peritoneal Mesothelioma.

Cushman TR, Verma V, Simone CB 2nd.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):767-768. doi: 10.1245/s10434-018-7021-5. Epub 2018 Nov 12. No abstract available.

PMID:
30421065
14.

Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.

Schonewolf CA, Heskel M, Doucette A, Singhal S, Frick MA, Xanthopoulos EP, Corradetti MN, Friedberg JS, Pechet TT, Christodouleas JP, Levin W, Berman A, Cengel KA, Verma V, Hahn SM, Kucharczuk JC, Rengan R, Simone CB 2nd.

Clin Lung Cancer. 2019 Jan;20(1):e63-e71. doi: 10.1016/j.cllc.2018.09.004. Epub 2018 Sep 20.

PMID:
30337269
15.

Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.

Rice SR, Molitoris JK, Vyfhuis MAL, Edelman MJ, Burrows WM, Feliciano J, Nichols EM, Suntharalingam M, Donahue J, Carr SR, Friedberg J, Badiyan S, Simone CB 2nd, Feigenberg SJ, Mohindra P.

Clin Lung Cancer. 2019 Jan;20(1):e107-e114. doi: 10.1016/j.cllc.2018.09.014. Epub 2018 Sep 24.

PMID:
30337268
16.

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.

PMID:
30266660
17.

Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.

Haefner MF, Verma V, Bougatf N, Mielke T, Tonndorf-Martini E, K├Ânig L, Rwigema JM, Simone CB 2nd, Uhlmann L, Eichhorn F, Winter H, Grosch H, Haberer T, Herfarth K, Debus J, Rieken S.

Acta Oncol. 2018 Sep 28:1-8. doi: 10.1080/0284186X.2018.1502467. [Epub ahead of print]

PMID:
30264630
18.

Integrative Wellness for Patients Receiving Proton Therapy: A Patient-Centered Collaboration.

Chiaramonte D, Kaiser A, McMath G, Simone CB 2nd, Regine WF, Berman B.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):1012-1013. doi: 10.1089/acm.2018.0172. No abstract available.

PMID:
30247956
19.

Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.

Frick MA, Kao GD, Aguarin L, Chinniah C, Swisher-McClure S, Berman AT, Levin WP, Cengel KA, DeCesaris C, Hahn SM, Dorsey JF, Simone CB 2nd.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):536-542. doi: 10.1016/j.ijrobp.2018.06.041. Epub 2018 Jul 2.

PMID:
30244877
20.

A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.

Jahangiri P, Pournazari K, Torigian DA, Werner TJ, Swisher-McClure S, Simone CB 2nd, Alavi A.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):206-216. doi: 10.1007/s00259-018-4154-5. Epub 2018 Sep 18.

PMID:
30229527
21.

Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.

Verma V, Ahern CA, Berlind CG, Lindsay WD, Shabason J, Sharma S, Culligan MJ, Grover S, Friedberg JS, Simone CB 2nd.

Clin Lung Cancer. 2018 Nov;19(6):e901-e912. doi: 10.1016/j.cllc.2018.08.007. Epub 2018 Aug 29.

PMID:
30224273
22.

Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma.

Cramer G, Simone CB 2nd, Busch TM, Cengel KA.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2565-S2573. doi: 10.21037/jtd.2018.07.65. Review.

23.

Reirradiation for locoregionally recurrent non-small cell lung cancer.

Vyfhuis MAL, Rice S, Remick J, Mossahebi S, Badiyan S, Mohindra P, Simone CB 2nd.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2522-S2536. doi: 10.21037/jtd.2017.12.50. Review.

24.

Combining immunotherapy with radiation therapy in thoracic oncology.

Badiyan SN, Roach MC, Chuong MD, Rice SR, Onyeuku NE, Remick J, Chilukuri S, Glass E, Mohindra P, Simone CB 2nd.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2492-S2507. doi: 10.21037/jtd.2018.05.73. Review.

25.

Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer.

Molitoris JK, Diwanji T, Snider JW 3rd, Mossahebi S, Samanta S, Badiyan SN, Simone CB 2nd, Mohindra P.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2437-S2450. doi: 10.21037/jtd.2018.01.155. Review.

26.

Advances in radiation therapy for thoracic malignancies.

Simone CB 2nd, Badiyan SN, Mohindra P.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2431-S2436. doi: 10.21037/jtd.2018.08.10. No abstract available.

27.

Hierarchical model-based object localization for auto-contouring in head and neck radiation therapy planning.

Tong Y, Udupa JK, Wu X, Odhner D, Pednekar G, Simone CB 2nd, McLaughlin D, Apinorasethkul C, Shammo G, James P, Camaratta J, Torigian DA.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10578. pii: 1057822. doi: 10.1117/12.2294042. Epub 2018 Mar 12.

28.

Auto-contouring via Automatic Anatomy Recognition of Organs at Risk in Head and Neck Cancer on CT images.

Wu X, Udupa JK, Tong Y, Odhner D, Pednekar GV, Simone CB 2nd, McLaughlin D, Apinorasethkul C, Lukens J, Mihailidis D, Shammo G, James P, Camaratta J, Torigian DA.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10576. pii: 1057617. doi: 10.1117/12.2293946. Epub 2018 Mar 13.

29.

Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer.

Xanthopoulos EP, Grover S, Puri PM, Corradetti MN, Heilbroner SP, Mitra N, Simone CB 2nd, Lin LL.

Am J Clin Oncol. 2018 Sep;41(9):845-850. doi: 10.1097/COC.0000000000000393.

PMID:
30134287
30.

Image Quality and Segmentation.

Pednekar GV, Udupa JK, McLaughlin DJ, Wu X, Tong Y, Simone CB 2nd, Camaratta J, Torigian DA.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10576. pii: 105762N. doi: 10.1117/12.2293622. Epub 2018 Mar 13.

31.

Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.

Verma V, Schonewolf CA, Cushman TR, Post CM, Doms A, Berman AT, DeVries M, Katz SI, Simone CB 2nd.

Clin Lung Cancer. 2018 Nov;19(6):502-510. doi: 10.1016/j.cllc.2018.07.005. Epub 2018 Jul 25.

PMID:
30111509
32.

The current state of neuro-palliative care.

Simone CB 2nd.

Ann Palliat Med. 2018 Jul;7(3):284-285. doi: 10.21037/apm.2018.07.01. No abstract available.

33.

How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.

Zhang Y, Shen J, Simone CB 2nd, Cappuzzo F, Fong KM, Rosell R, Chang JY, Ampollini L, Choi JI, He J, Jiang T; Written on behalf of AME Lung Cancer Cooperative Group.

J Thorac Dis. 2018 Jun;10(6):3883-3890. doi: 10.21037/jtd.2018.06.101. No abstract available.

34.

Validation and clinical implementation of an accurate Monte Carlo code for pencil beam scanning proton therapy.

Huang S, Kang M, Souris K, Ainsley C, Solberg TD, McDonough JE, Simone CB 2nd, Lin L.

J Appl Clin Med Phys. 2018 Sep;19(5):558-572. doi: 10.1002/acm2.12420. Epub 2018 Jul 30.

35.

Advances in proton therapy in lung cancer.

Vyfhuis MAL, Onyeuku N, Diwanji T, Mossahebi S, Amin NP, Badiyan SN, Mohindra P, Simone CB 2nd.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618783878. doi: 10.1177/1753466618783878. Review.

36.

Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: practice patterns and outcomes from the national cancer data base.

Verma V, Kusi Appiah A, Lautenschlaeger T, Adeberg S, Simone CB 2nd, Lin C.

J Gastrointest Oncol. 2018 Jun;9(3):527-535. doi: 10.21037/jgo.2018.01.15.

37.

Exploratory analysis using machine learning to predict for chest wall pain in patients with stage I non-small-cell lung cancer treated with stereotactic body radiation therapy.

Chao HH, Valdes G, Luna JM, Heskel M, Berman AT, Solberg TD, Simone CB 2nd.

J Appl Clin Med Phys. 2018 Sep;19(5):539-546. doi: 10.1002/acm2.12415. Epub 2018 Jul 10.

38.

Acute Hospital Encounters in Cancer Patients Treated With Definitive Radiation Therapy.

Marar M, Gabriel P, Hwang WT, Owen DR, Ju M, Simone CB 2nd, Christodouleas J, Vapiwala N, Berman AT.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):935-944. doi: 10.1016/j.ijrobp.2018.04.025. Epub 2018 Apr 18.

PMID:
29976506
39.

Disparities in Perioperative Radiation Therapy Use in Elderly Patients With Soft-Tissue Sarcoma.

Venigalla S, Carmona R, VanderWalde N, Sebro R, Sharma S, Simone CB 2nd, Wilson RJ 2nd, Weber KL, Shabason JE.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):155-165. doi: 10.1016/j.ijrobp.2018.05.019. Epub 2018 May 14.

PMID:
29958721
40.

Cardiac mortality in limited-stage small cell lung cancer.

Verma V, Fakhreddine MH, Haque W, Butler EB, Teh BS, Simone CB 2nd.

Radiother Oncol. 2018 Sep;128(3):492-497. doi: 10.1016/j.radonc.2018.06.011. Epub 2018 Jun 19.

PMID:
29934110
41.

Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.

Verma V, Choi JI, Sawant A, Gullapalli RP, Chen W, Alavi A, Simone CB 2nd.

Semin Radiat Oncol. 2018 Jun;28(3):171-177. doi: 10.1016/j.semradonc.2018.02.001. Review.

PMID:
29933876
42.

Margins and Uncertainties in Radiation Oncology.

Simone CB 2nd, Sawant A.

Semin Radiat Oncol. 2018 Jun;28(3):169-170. doi: 10.1016/j.semradonc.2018.03.001. No abstract available.

PMID:
29933875
43.

Proton beam therapy for malignant pleural mesothelioma.

Badiyan SN, Molitoris JK, Zhu M, Glass E, Diwanji T, Simone CB 2nd.

Transl Lung Cancer Res. 2018 Apr;7(2):189-198. doi: 10.21037/tlcr.2018.04.07. Review.

44.

Particle therapy in non-small cell lung cancer.

Liao Z, Simone CB 2nd.

Transl Lung Cancer Res. 2018 Apr;7(2):141-152. doi: 10.21037/tlcr.2018.04.11. Review.

45.

Proton therapy for small cell lung cancer.

Verma V, Choi JI, Simone CB 2nd.

Transl Lung Cancer Res. 2018 Apr;7(2):134-140. doi: 10.21037/tlcr.2018.04.02. Review.

46.

Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.

Shaaban SG, Verma V, Choi JI, Shabason J, Sharma S, Glass E, Grover S, Badiyan SN, Simone CB 2nd.

Clin Lung Cancer. 2018 Sep;19(5):e685-e692. doi: 10.1016/j.cllc.2018.04.019. Epub 2018 May 5.

PMID:
29803576
47.

A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy.

Davis RW 4th, Papasavvas E, Klampatsa A, Putt M, Montaner LJ, Culligan MJ, McNulty S, Friedberg JS, Simone CB 2nd, Singhal S, Albelda SM, Cengel KA, Busch TM.

Lasers Surg Med. 2018 Jul;50(5):440-450. doi: 10.1002/lsm.22934. Epub 2018 May 25.

PMID:
29799130
48.

Symptom control, treatment-induced nausea prophylaxis, and palliative radiation therapy.

Simone CB 2nd.

Ann Palliat Med. 2018 Apr;7(2):E2-E4. doi: 10.21037/apm.2018.05.09. No abstract available.

49.

Public health approaches to palliative care.

Simone CB 2nd.

Ann Palliat Med. 2018 Apr;7(Suppl 2):E1. doi: 10.21037/apm.2018.05.03. No abstract available.

50.

Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.

Verma V, Ahern CA, Berlind CG, Lindsay WD, Grover S, Culligan MJ, Friedberg JS, Simone CB 2nd.

Lung Cancer. 2018 Jun;120:7-13. doi: 10.1016/j.lungcan.2018.03.019. Epub 2018 Mar 21.

PMID:
29748018

Supplemental Content

Loading ...
Support Center